Improving understanding of chromatin regulatory proteins and potential implications for drug discovery

References

• Van Speybroeck L. From epigenesis to epigenetics: the case of C. H Waddington Ann N Y Acad Sci. 2002;981:61–81.
   PubMed Web of Science ®Google Scholar
• Kobow K, Blumcke I. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia. 2011;52(Suppl 4):15–19.
   PubMed Web of Science ®Google Scholar
• Martin-Subero JI, Esteller M. Profiling epigenetic alterations in disease. Adv Exp Med Biol. 2011;711:162–177.
   PubMed Web of Science ®Google Scholar
• Martin-Subero JI. How epigenomics brings phenotype into being. Pediatr Endocrinol Rev: PER. 2011;9(Suppl 1):506–510.
   PubMedGoogle Scholar
• Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011;123(19):2145–2156.
   PubMed Web of Science ®Google Scholar
• Zhao J, Grant SF. Advances in whole genome sequencing technology. Curr Pharm Biotechnol. 2011;12(2):293–305.
   PubMed Web of Science ®Google Scholar
• Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat rev Genet. 2009;10(1):57–63.
   PubMed Web of Science ®Google Scholar
• Hurd PJ, Nelson CJ. Advantages of next-generation sequencing versus the microarray in epigenetic research. Brief Funct Genomic Proteomic. 2009;8(3):174–183.
   PubMedGoogle Scholar
• Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat rev Genet. 2010;11(7):476–486.
   PubMed Web of Science ®Google Scholar
• Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13(9):673–691.
   PubMed Web of Science ®Google Scholar
• ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science. 2004;306(5696):636–640.
   PubMed Web of Science ®Google Scholar
• Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447(7146):799–816.
   PubMed Web of Science ®Google Scholar
• ENCODE Project Consortium. A user’s guide to the encyclopedia of DNA elements (ENCODE). Plos Biology. 2011;9(4):e1001046.
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Stamatoyannopoulos JA, Costello JF, et al. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol. 2010;28(10):1045–1048.
   PubMed Web of Science ®Google Scholar
• GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580–585.
   PubMed Web of Science ®Google Scholar
• Martens JH, Stunnenberg HG. Blueprint: mapping human blood cell epigenomes. Haematologica. 2013;98(10):1487–1489.
   PubMed Web of Science ®Google Scholar
• Phillips DM. The presence of acetyl groups of histones. Biochem J. 1963;87:258–263.
   PubMed Web of Science ®Google Scholar
• Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of Rna synthesis. Proc Natl Acad Sci USA. 1964;51:786–794.
   PubMed Web of Science ®Google Scholar
• Pogo BG, Allfrey VG, Mirsky AE. RNA synthesis and histone acetylation during the course of gene activation in lymphocytes. Proc Natl Acad Sci USA. 1966;55(4):805–812.
   PubMed Web of Science ®Google Scholar
• Verdone L, Caserta M, Di Mauro E. Role of histone acetylation in the control of gene expression. Biochem Cell Biol. 2005;83(3):344–353.
   PubMed Web of Science ®Google Scholar
• Hong L, Schroth GP, Matthews HR, et al. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 “tail” to DNA. J Biol Chem. 1993;268(1):305–314.
   PubMed Web of Science ®Google Scholar
• Megee PC, Morgan BA, Smith MM. Histone H4 and the maintenance of genome integrity. Genes Dev. 1995;9(14):1716–1727.
   PubMed Web of Science ®Google Scholar
• Dion MF, Altschuler SJ, Wu LF, et al. Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci USA. 2005;102(15):5501–5506.
   PubMed Web of Science ®Google Scholar
• Bjerling P, Silverstein RA, Thon G, et al. Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity. Mol Cell Biol. 2002;22(7):2170–2181.
   PubMed Web of Science ®Google Scholar
• Barth TK, Imhof A. Fast signals and slow marks: the dynamics of histone modifications. Trends Biochem Sci. 2010;35(11):618–626.
   PubMed Web of Science ®Google Scholar
• Waterborg JH. Dynamics of histone acetylation in vivo. A function for acetylation turnover? Biochem Cell Biol. 2002;80(3):363–378.
   PubMed Web of Science ®Google Scholar
• Brownell JE, Allis CD. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev. 1996;6(2):176–184.
   PubMed Web of Science ®Google Scholar
• de Ruijter AJ, van Gennip AH, Caron HN, et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370(Pt 3):737–749.
   PubMed Web of Science ®Google Scholar
• Wade PA. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet. 2001;10(7):693–698.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Molecular Cell. 2008;31(4):449–461.
   PubMed Web of Science ®Google Scholar
• Yang XJ. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays. 2004;26(10):1076–1087.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? The EMBO Journal. 2000;19(6):1176–1179.
   PubMed Web of Science ®Google Scholar
• Hubbert C, Guardiola A, Shao R, et al. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417(6887):455–458.
   PubMed Web of Science ®Google Scholar
• Choudhary C, Kumar C, Gnad F, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834–840.
   PubMed Web of Science ®Google Scholar
• Marks PA, Xu WS. Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem. 2009;107(4):600–608.
   PubMed Web of Science ®Google Scholar
• Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol. 2001;21(17):5979–5991.
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Suhara W, Fujita T. Control of IRF-3 activation by phosphorylation. J Interferon Cytokine Res. 2002;22(1):73–76.
   PubMed Web of Science ®Google Scholar
• Icardi L, De Bosscher K, Tavernier J. The HAT/HDAC interplay: multilevel control of STAT signaling. Cytokine Growth Factor Rev. 2012;23(6):283–291.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zang C, Cui K, et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 2009;138(5):1019–1031.
   PubMed Web of Science ®Google Scholar
• Christensen DP, Gysemans C, Lundh M, et al. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and beta-cell protection. Proc Natl Acad Sci USA. 2014;111(3):1055–1059.
   PubMed Web of Science ®Google Scholar
• Cao DJ, Wang ZV, Battiprolu PK, et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA. 2011;108(10):4123–4128.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Kijima M, Akita M, et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem. 1990;265(28):17174–17179.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res. 1988;177(1):122–131.
   PubMed Web of Science ®Google Scholar
• Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol. 2007;25(1):84–90.
   PubMed Web of Science ®Google Scholar
• Shabason JE, Tofilon PJ, Camphausen K. HDAC inhibitors in cancer care. Oncology (Williston Park). 2010;24(2):180–185.
   PubMed Web of Science ®Google Scholar
• Garnock-Jones KP. Panobinostat: first global approval. Drugs. 2015;75(6):695–704.
   PubMed Web of Science ®Google Scholar
• Henry TR. The history of valproate in clinical neuroscience. Psychopharmacol Bull. 2003;37(Suppl 2):5–16.
   PubMedGoogle Scholar
• Li X, Zhang J, Xie Y, et al. Progress of HDAC inhibitor panobinostat in the treatment of cancer. Current Drug Targets. 2014;15(6):622–634.
   PubMed Web of Science ®Google Scholar
• Finazzi G, Vannucchi AM, Martinelli V, et al. A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. Br J Haematol. 2013;161(5):688–694.
   PubMed Web of Science ®Google Scholar
• Gottlicher M, Minucci S, Zhu P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. The EMBO Journal. 2001;20(24):6969–6978.
   PubMed Web of Science ®Google Scholar
• Sawa H, Murakami H, Ohshima Y, et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol. 2002;19(2):77–81.
   PubMedGoogle Scholar
• Dangond F, Gullans SR. Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem Biophys Res Commun. 1998;247(3):833–837.
   PubMed Web of Science ®Google Scholar
• Khan N, Jeffers M, Kumar S, et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. ‎Biochem J . 2008;409(2):581–589.
   PubMed Web of Science ®Google Scholar
• Hsu YF, Sheu JR, Lin CH, et al. MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide. Biochim Biophys Acta. 2011;1810(12):1160–1169.
   PubMed Web of Science ®Google Scholar
• Olson EN, Backs J, McKinsey TA. Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation. Novartis Found Symp. 2006;274(3–12): discussion 13-19, 152–155, 272–156.
   PubMedGoogle Scholar
• Majumdar G, Rooney RJ, Johnson IM, et al. Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy. Physiol Genomics. 2011;43(24):1319–1333.
   PubMed Web of Science ®Google Scholar
• Rafehi H, Balcerczyk A, Lunke S, et al. Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res. 2014;24(8):1271–1284.
   PubMed Web of Science ®Google Scholar
• Ooi JY, Tuano NK, Rafehi H, et al. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Epigenet: off J DNA Methyla Soc. 2015;10(5):418–430.
   PubMed Web of Science ®Google Scholar
• Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006.
   PubMed Web of Science ®Google Scholar
• Hansson ML, Popko-Scibor AE, Saint Just Ribeiro M, et al. The transcriptional coactivator MAML1 regulates p300 autoacetylation and HAT activity. Nucleic Acids Res. 2009;37(9):2996–3006.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu J, Sinha SH, et al. Autoacetylation of the MYST lysine acetyltransferase MOF protein. J Biol Chem. 2012;287(42):34917–34926.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu J, Zheng YG. Function of the active site lysine autoacetylation in Tip60 catalysis. Plos One. 2012;7(3):e32886.
   PubMed Web of Science ®Google Scholar
• Albaugh BN, Arnold KM, Lee S, et al. Autoacetylation of the histone acetyltransferase Rtt109. J Biol Chem. 2011;286(28):24694–24701.
   PubMed Web of Science ®Google Scholar
• Blanco-Garcia N, Asensio-Juan E, de la Cruz X, et al. Autoacetylation regulates P/CAF nuclear localization. J Biol Chem. 2009;284(3):1343–1352.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kang HJ, Na H, et al. Enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. Breast Cancer Research: BCR. 2010;12(2):R22.
   PubMed Web of Science ®Google Scholar
• Wang CY, Filippakopoulos P. Beating the odds: BETs in disease. Trends Biochem Sci. 2015;40(8):468–479.
   PubMed Web of Science ®Google Scholar
• Brown JD, Lin CY, Duan Q, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Molecular Cell. 2014;56(2):219–231.
   PubMed Web of Science ®Google Scholar
• Shi J, Vakoc CR. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Molecular Cell. 2014;54(5):728–736.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320–334.
   PubMed Web of Science ®Google Scholar
• Anders L, Guenther MG, Qi J, et al. Genome-wide localization of small molecules. Nat Biotechnol. 2014;32(1):92–96.
   PubMed Web of Science ®Google Scholar
• Dambacher S, Hahn M, Schotta G. Epigenetic regulation of development by histone lysine methylation. Heredity. 2010;105(1):24–37.
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Birney E, Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74.
   PubMed Web of Science ®Google Scholar
• Voigt P, Tee WW, Reinberg D. A double take on bivalent promoters. Genes Dev. 2013;27(12):1318–1338.
   PubMed Web of Science ®Google Scholar
• Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 2016;22(2):128–134.
   PubMed Web of Science ®Google Scholar
• McCabe MT, Ott HM, Ganji G, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012;492(7427):108–112.
   PubMed Web of Science ®Google Scholar
• Knutson SK, Kawano S, Minoshima Y, et al. Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma. Mol Cancer Ther. 2014;13(4):842–854.
   PubMed Web of Science ®Google Scholar
• Chen CW, Koche RP, Sinha AU, et al. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat Med. 2015;21(4):335–343.
   PubMed Web of Science ®Google Scholar
• Wagner T, Jung M. New lysine methyltransferase drug targets in cancer. Nat Biotechnol. 2012;30(7):622–623.
   PubMed Web of Science ®Google Scholar
• Peterson CL, Laniel MA. Histones and histone modifications. Curr Biol. 2004;14(14):R546–551.
   PubMed Web of Science ®Google Scholar
• Spencer VA, Sun JM, Li L, et al. Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods. 2003;31(1):67–75.
   PubMed Web of Science ®Google Scholar
• O’Neill LP, Turner BM. Immunoprecipitation of native chromatin: NChIP. Methods. 2003;31(1):76–82.
   PubMed Web of Science ®Google Scholar
• Solomon MJ, Larsen PL, Varshavsky A. Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell. 1988;53(6):937–947.
   PubMed Web of Science ®Google Scholar
• Schmidl C, Rendeiro AF, Sheffield NC, et al. ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors. Nat Methods. 2015;12(10):963–965.
   PubMed Web of Science ®Google Scholar
• Lambert JP, Mitchell L, Rudner A, et al. A novel proteomics approach for the discovery of chromatin-associated protein networks. Mol Cell Proteomics. 2009;8(4):870–882.
   PubMedGoogle Scholar
• Wang CI, Alekseyenko AA, LeRoy G, et al. Chromatin proteins captured by ChIP-mass spectrometry are linked to dosage compensation in Drosophila. Nat Struct Mol Biol. 2013;20(2):202–209.
   PubMed Web of Science ®Google Scholar
• Soldi M, Bonaldi T. The proteomic investigation of chromatin functional domains reveals novel synergisms among distinct heterochromatin components. Mol Cell Proteomics. 2013;12(3):764–780.
   PubMed Web of Science ®Google Scholar
• Keene JD, Komisarow JM, Friedersdorf MB. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc. 2006;1(1):302–307.
   PubMed Web of Science ®Google Scholar
• Niranjanakumari S, Lasda E, Brazas R, et al. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods. 2002;26(2):182–190.
   PubMed Web of Science ®Google Scholar
• Engreitz JM, Pandya-Jones A, McDonel P, et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science. 2013;341(6147):1237973.
   PubMed Web of Science ®Google Scholar
• Chu C, Qu K, Zhong FL, et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Molecular Cell. 2011;44(4):667–678.
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Ilik IA, Qu K, et al. Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification. Nat Biotechnol. 2014;32(9):933–940.
   PubMed Web of Science ®Google Scholar
• Ule J, Jensen K, Mele A, et al. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods. 2005;37(4):376–386.
   PubMed Web of Science ®Google Scholar
• Hafner M, Landthaler M, Burger L, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141(1):129–141.
   PubMed Web of Science ®Google Scholar
• Hafner M, Landthaler M, Burger L, et al. PAR-CliP–a method to identify transcriptome-wide the binding sites of RNA binding proteins. J Visualized Exp: JoVE. 2010;(41).
   Google Scholar
• Konig J, Zarnack K, Rot G, et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol. 2010;17(7):909–915.
   PubMed Web of Science ®Google Scholar
• Granneman S, Kudla G, Petfalski E, et al. Identification of protein binding sites on U3 snoRNA and pre-rRNA by UV cross-linking and high-throughput analysis of cDNAs. Proc Natl Acad Sci USA. 2009;106(24):9613–9618.
   PubMed Web of Science ®Google Scholar
• Kudla G, Granneman S, Hahn D, et al. Cross-linking, ligation, and sequencing of hybrids reveals RNA-RNA interactions in yeast. Proc Natl Acad Sci USA. 2011;108(24):10010–10015.
   PubMed Web of Science ®Google Scholar
• Simon MD, Wang CI, Kharchenko PV, et al. The genomic binding sites of a noncoding RNA. Proc Natl Acad Sci USA. 2011;108(51):20497–20502.
   PubMed Web of Science ®Google Scholar
• Kustatscher G, Wills KL, Furlan C, et al. Chromatin enrichment for proteomics. Nat Protoc. 2014;9(9):2090–2099.
   PubMed Web of Science ®Google Scholar
• Byrum SD, Raman A, Taverna SD, et al. ChAP-MS: a method for identification of proteins and histone posttranslational modifications at a single genomic locus. Cell Rep. 2012;2(1):198–205.
   PubMed Web of Science ®Google Scholar
• Dejardin J, Kingston RE. Purification of proteins associated with specific genomic Loci. Cell. 2009;136(1):175–186.
   PubMed Web of Science ®Google Scholar
• Rotem A, Ram O, Shoresh N, et al. Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state. Nat Biotechnol. 2015;33(11):1165–1172.
   PubMed Web of Science ®Google Scholar
• Macosko EZ, Basu A, Satija R, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161(5):1202–1214.
   PubMed Web of Science ®Google Scholar
• Ramskold D, Luo S, Wang YC, et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012;30(8):777–782.
   PubMed Web of Science ®Google Scholar
• Stegle O, Teichmann SA, Marioni JC. Computational and analytical challenges in single-cell transcriptomics. Nat Rev Genet. 2015;16(3):133–145.
   PubMed Web of Science ®Google Scholar
• Mallinjoud P, Villemin JP, Mortada H, et al. Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin. Genome Res. 2014;24(3):511–521.
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Miller KM. Unravelling the genomic targets of small molecules using high-throughput sequencing.. Nat Rev Genet. 2014;15(12):783–796.
   PubMed Web of Science ®Google Scholar